mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.007 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.69 |
0.009 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.02 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |